EN
TR
REAL WORLD EVIDENCE AND BIG DATA
Abstract
Knowledge has been the key to better organization and new developments. With more information, what kind of arrangement and organization is needed
to present the best? Indeed, data collection on its subject is an essential part of any organization. Beyond the purpose of accurately reflecting the current
status of certain criteria, these data can also be used for anticipatory-predictive prediction of future trends, and this process is carried out considering that
this can have many benefits.
Today, this knowledge accumulation and evaluation effort has created the need to deal with tons of data from all areas of our lives such as security, social
activities, science, work, and health. But after a point, this ‘data storm’ flow, provided by current technologies, became unmanageable with the
technologies at hand, the number of experts who could evaluate and interpret, and the time that could be allocated. In this way, the term ‘big data’ was
coined to describe large and no longer adequately manageable data. Now there is a need for new strategies that will allow us to organize the data and
produce useful information, to use this big data to meet various future needs. This has become so important that a new field of science called ‘data Science’
has emerged. data science; It deals with data management for the flow, storage, classification-management of data and its analysis in order to obtain
deeper estimations, and it is of great importance in the functionality or services of the system that will provide this.
Keywords
References
- Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109(15):276-81.
Details
Primary Language
English
Subjects
Clinical Sciences
Journal Section
Meeting Abstract
Authors
Publication Date
August 9, 2022
Submission Date
June 17, 2022
Acceptance Date
July 3, 2022
Published in Issue
Year 2022 Volume: 5 Number: S-1
APA
Günver, M. G. (2022). REAL WORLD EVIDENCE AND BIG DATA. Journal of Advanced Research in Health Sciences, 5(S-1), 33-33. https://doi.org/10.26650/JARHS2021-1132473
AMA
1.Günver MG. REAL WORLD EVIDENCE AND BIG DATA. Journal of Advanced Research in Health Sciences. 2022;5(S-1):33-33. doi:10.26650/JARHS2021-1132473
Chicago
Günver, Mehmet Güven. 2022. “REAL WORLD EVIDENCE AND BIG DATA”. Journal of Advanced Research in Health Sciences 5 (S-1): 33-33. https://doi.org/10.26650/JARHS2021-1132473.
EndNote
Günver MG (August 1, 2022) REAL WORLD EVIDENCE AND BIG DATA. Journal of Advanced Research in Health Sciences 5 S-1 33–33.
IEEE
[1]M. G. Günver, “REAL WORLD EVIDENCE AND BIG DATA”, Journal of Advanced Research in Health Sciences, vol. 5, no. S-1, pp. 33–33, Aug. 2022, doi: 10.26650/JARHS2021-1132473.
ISNAD
Günver, Mehmet Güven. “REAL WORLD EVIDENCE AND BIG DATA”. Journal of Advanced Research in Health Sciences 5/S-1 (August 1, 2022): 33-33. https://doi.org/10.26650/JARHS2021-1132473.
JAMA
1.Günver MG. REAL WORLD EVIDENCE AND BIG DATA. Journal of Advanced Research in Health Sciences. 2022;5:33–33.
MLA
Günver, Mehmet Güven. “REAL WORLD EVIDENCE AND BIG DATA”. Journal of Advanced Research in Health Sciences, vol. 5, no. S-1, Aug. 2022, pp. 33-33, doi:10.26650/JARHS2021-1132473.
Vancouver
1.Mehmet Güven Günver. REAL WORLD EVIDENCE AND BIG DATA. Journal of Advanced Research in Health Sciences. 2022 Aug. 1;5(S-1):33-. doi:10.26650/JARHS2021-1132473